Director dealings: Joy takes advantage of Biotech Growth slump
10th Mar 2016 14:50
(ShareCast News) - Andrew Joy, senior independent director in the Biotech Growth Trust, has bought almost £180,000 worth of shares in the FTSE listed investment trust after they fell by more than a third since last summer's peak. Joy, who is a founding partner and investment committee member of Euro
Read moreShire Chairman sells shares following 'excellent' 2013 results
21st Feb 2014 15:26
Shire's Chairman, Matthew Emmens, has sold 36,100 shares in the biopharmaceutical company following its 'excellent' results for 2013. Emmens disposed of the shares at 3,314.85p each for a total of just under £1.2m shares. After a pick-up in earnings growth in the fourth quarter, the group beat f
Read moreRolls Royce director makes sale
5th Mar 2013 15:49
The President and Chief Executive Officer of Rolls-Royce North America, James Guyette, was once again seen selling shares, this time following the vesting of shares awarded under the company's performance share plan. Guyette was awarded 137,075 shares and subsequently sold 55,900 of them, earning £
Read moreChariot Chairman buys 100,000 shares
15th May 2012 16:15
Co-founder and Non-Executive Chairman of Chariot Oil and Gas, an Africa-focused exploration company, Adonis Pouroulis, has scooped up 100,000 shares in the firm. He made the purchase on Tuesday, the same day the company admitted that the Tapir South well (1811/5-1), offhore Namibia, failed to find
Read moreInstem acquires BioWisdom
4th Mar 2011 18:17
Healthcare IT services provider Instem Life Sciences is buying Cambridge-based BioWisdom, which supplies software to analyse R&D-related healthcare data. AIM-quoted Instem is paying an initial enterprise value of £900,000, although that figure could increase to £1.5m depending on performance in 20
Read moreBiotech Growth Trust NAV 182.6P At March 31
16th Jun 2010 15:08
LONDON (Dow Jones)--The Biotech Growth Trust PLC (BIOG.LN) said Wednesday its net asset value per share at March 31 was 182.6 pence (March 31, 2009: 136.9 pence) -NASDAQ Biotechnology Index 618.1 (2009: 477.5) -Shareholders' funds GBP120.4 million (2009: GBP70.2 million) -During the full
Read moreEdinburgh chairman splashes out
24th Jul 2009 17:12
Scott Dobbie, chairman of Edinburgh Investment Trust, has made a significant addition to his personal holding in the Invesco-managed trust. Dobbie, who also chairs the Securities & Investment Institute, bought a further 80,000 ordinary shares this week at a cost of £266,400 to take his stake to mo
Read more